LISATA THERAPEUTICS, INC. — Director's Dealing 2011

May 17, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-05-13

Reporting Person: Smith Robin L (Director, Chairman of Board and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-05-13	Common Stock, $0.001 par value	A	5111	$1.67	Acquired	1002075	Direct

Footnotes

F1: On February 18, 2011, the Board of Directors approved an arrangement whereby Dr. Smith will receive her net salary for the
period February 16, 2011 through May 15, 2011 through the issuance to her by the Company of shares of its common stock at
the then market price, under and subject to all the terms and conditions of the Company's 2009 Equity Compensation Plan (the
"2009 Plan").